Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.

Ammassari A, Stöhr W, Antinori A, Molina JM, Schwimmer C, Domingo P, Thalme A, Di Pietro M, Wallet C, Pozniak A, Richert L, Raffi F; NEAT001/ANRS143 Trial Study Group.

J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):481-490. doi: 10.1097/QAI.0000000000001834.

2.

Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined with Either Raltegravir or Tenofovir Disoproxil Fumarate /Emtricitabine in the Neat 001/Anrs 143 Trial.

Ammassari A, Stöhr W, Antinori A, Molina JM, Schwimmer C, Domingo P, Thalme A, Di Pietro M, Wallet C, Pozniak A, Richert L, Raffi F; and the NEAT 001/ANRS 143 Trial Study Group.

J Acquir Immune Defic Syndr. 2018 Aug 27. doi: 10.1097/QAI.0000000000001834. [Epub ahead of print]

PMID:
30153121
3.

Population pharmacokinetics of ritonavir-boosted atazanavir in HIV-infected patients and healthy volunteers.

Dickinson L, Boffito M, Back D, Waters L, Else L, Davies G, Khoo S, Pozniak A, Aarons L.

J Antimicrob Chemother. 2009 Jun;63(6):1233-43. doi: 10.1093/jac/dkp102. Epub 2009 Mar 28.

4.

Population trends in the prevalence and patterns of protease resistance related to exposure to unboosted and boosted protease inhibitors.

Dunn D, Geretti AM, Green H, Fearnhill E, Pozniak A, Churchill D, Pillay D, Sabin C, Phillips A; UK Collaborative Group on HIV Drug Resistance; UK Collaborative HIV Cohort Study.

Antivir Ther. 2008;13(6):771-7.

PMID:
18839778
5.

Population pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.

Dickinson L, Boffito M, Back DJ, Khoo SH, Pozniak AL, Mugyenyi P, Merry C, Autar RS, Burger DM, Aarons LJ.

J Antimicrob Chemother. 2008 Dec;62(6):1344-55. doi: 10.1093/jac/dkn399. Epub 2008 Sep 29.

6.

A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects.

Pozniak AL, Boffito M, Russell D, Ridgway CE, Muirhead GJ.

Br J Clin Pharmacol. 2008 Apr;65 Suppl 1:54-9. doi: 10.1111/j.1365-2125.2008.03136.x.

7.

Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.

Ford J, Boffito M, Maitland D, Hill A, Back D, Khoo S, Nelson M, Moyle G, Gazzard B, Pozniak A.

J Antimicrob Chemother. 2006 Nov;58(5):1009-16. Epub 2006 Sep 19.

PMID:
16984898
8.

Naively changing HAART.

Mandalia S, Parmar D, Fisher M, Pozniak A, Tang A, Youle M, Gazzard B, Beck EJ; NPMS-HHC Steering Group.

HIV Med. 2002 Oct;3(4):254-62.

9.

Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance.

Walsh JC, Pozniak AL, Nelson MR, Mandalia S, Gazzard BG.

J Acquir Immune Defic Syndr. 2002 Jul 1;30(3):278-87.

PMID:
12131564
10.

Mycobacterial diseases and HIV.

Pozniak A.

J HIV Ther. 2002 Feb;7(1):13-6. Review.

PMID:
11956499
11.

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL.

AIDS. 2002 Jan 4;16(1):75-83.

PMID:
11741165
12.

AIDS survival and progression in black Africans living in south London, 1986-1994.

Low N, Paine K, Clark R, Mahalingam M, Pozniak AL.

Genitourin Med. 1996 Feb;72(1):12-6.

13.

AIDS in Africans living in London.

O'Farrell N, Lau R, Yoganathan K, Bradbeer CS, Griffin GE, Pozniak AL.

Genitourin Med. 1995 Dec;71(6):358-62.

14.

A pilot study of low-dose recombinant human granulocyte-macrophage colony-stimulating factor in chronic neutropenia.

Kaczmarski RS, Pozniak A, Lakhani A, Harvey E, Mufti GJ.

Br J Haematol. 1993 Jun;84(2):338-40.

PMID:
8398839
15.

A comparison of direct and indirect measurements of oxygen delivery and consumption: the effects of prostacyclin in two human volunteers.

Bihari DJ, Smithies M, Pozniak A, Gimson A.

Scand J Clin Lab Invest Suppl. 1987;188:37-45.

PMID:
3329764

Supplemental Content

Loading ...
Support Center